trending Market Intelligence /marketintelligence/en/news-insights/trending/c991gqkz9feE8T4sSKH4Pg2 content esgSubNav
In This List

Antibe Therapeutics completes private placement, raises C$2.7M

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Antibe Therapeutics completes private placement, raises C$2.7M

Antibe Therapeutics Inc. completed the second and final closing of its private placement, raising another C$297,750 in gross proceeds to bolster the C$2.4 million raised in the first tranche of the offering.

The net proceeds of approximately C$2.7 million will be used for clinical development and general purposes.

The issued securities are subject to a four-month statutory hold period and a TSX Venture Exchange hold period, each expiring April 22, 2017.